CalciMedica, Inc. filed a Certificate of Amendment to enact a 1-for-5 reverse stock split of its common stock, effective at 5:00 p.m. ET on August 28, 2026. Concurrently, the company will reduce its total number of authorized shares of common stock from 500 million to 100 million.

Key Details

  • Reverse Split Ratio: Every five shares of issued and outstanding common stock will be combined into one share. The company's stock will begin trading on a split-adjusted basis at the market open on August 31, 2026.
  • Authorized Share Reduction: The total number of authorized shares of common stock will be reduced from 500,000,000 to 100,000,000.
  • Trading Information: The stock will continue to trade on The Nasdaq Capital Market under the ticker symbol "CALC" but will have a new CUSIP number (38942Q301).
  • Fractional Shares: No fractional shares will be issued. Stockholders who would otherwise be entitled to a fractional share will receive a cash payment.